Cargando…
A Mechanism for Statin-Induced Susceptibility to Myopathy
This study aimed to identify a mechanism for statin-induced myopathy that explains its prevalence and selectivity for skeletal muscle, and to understand its interaction with moderate exercise. Statin-associated adverse muscle symptoms reduce adherence to statin therapy; this limits the effectiveness...
Autores principales: | Lotteau, Sabine, Ivarsson, Niklas, Yang, Zhaokang, Restagno, Damien, Colyer, John, Hopkins, Philip, Weightman, Andrew, Himori, Koichi, Yamada, Takashi, Bruton, Joseph, Steele, Derek, Westerblad, Håkan, Calaghan, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712048/ https://www.ncbi.nlm.nih.gov/pubmed/31468006 http://dx.doi.org/10.1016/j.jacbts.2019.03.012 |
Ejemplares similares
-
Impaired Ca(2+) release contributes to muscle weakness in a rat model of critical illness myopathy
por: Llano-Diez, Monica, et al.
Publicado: (2016) -
Muscle dysfunction associated with adjuvant-induced arthritis is prevented by antioxidant treatment
por: Yamada, Takashi, et al.
Publicado: (2015) -
α-Actinin-3: Why Gene Loss Is an Evolutionary Gain
por: Ivarsson, Niklas, et al.
Publicado: (2015) -
Simvastatin activates single skeletal RyR1 channels but exerts more complex regulation of the cardiac RyR2 isoform
por: Venturi, Elisa, et al.
Publicado: (2018) -
Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension
por: Himori, Koichi, et al.
Publicado: (2017)